Ioannis Tomos
Overview
    Explore the profile of Ioannis Tomos including associated specialties, affiliations and a list of published articles.
          
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              34
            
            
              Citations
              118
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          Published In
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Fabbri L, Althobiani M, Tomos I, Planas-Cerezales L, Wijsenbeek M, Kreuter M, et al.
  
  
    ERJ Open Res
    . 2025 Mar;
          11(2).
    
    PMID: 40071274
  
  
          https://bit.ly/3WAhw19.
      
2.
        
    
    Tomos I, Grigoropoulos I, Kosti C, Chrysikos S, Digalaki A, Thomas K, et al.
  
  
    Expert Rev Respir Med
    . 2025 Feb;
          :1-9.
    
    PMID: 40017107
  
  
          Background: Immunomodulators tocilizumab and baricitinib have been used for the treatment of severe COVID-19, however, there are only few published studies comparing their efficacy. Research Design And Methods: All consecutive...
      
3.
        
    
    Tomos I, Antonogiannaki E, Dimakopoulou K, Raptakis T, Apollonatou V, Kallieri M, et al.
  
  
    Expert Rev Respir Med
    . 2025 Feb;
          :1-8.
    
    PMID: 40007128
  
  
          Background: The use of lung ultrasound (LUS) has recently become vital in the diagnosis and prognosis of various respiratory diseases. Its role in COVID-19 requires further investigation. Research Design And...
      
4.
        
    
    Tomos I, Kanellopoulou P, Nastos D, Aidinis V
  
  
    Expert Opin Ther Targets
    . 2025 Feb;
          29(1-2):43-57.
    
    PMID: 39985559
  
  
          Introduction: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive interstitial lung disease with a dismal prognosis. While the standard-of-care (SOC) drugs approved for IPF represent a significant advancement in antifibrotic...
      
5.
        
    
    Matthaiou A, Tomos I, Bizymi N, Vamvakaris I, Anagnostopoulos N, Papadopoulou A, et al.
  
  
    Biomol Biomed
    . 2025 Jan;
    
    PMID: 39888726
  
  
          SWItch/sucrose non-fermentable (SWI/SNF) is a large protein complex with a central role in chromatin remodeling and genome transcription. The catalytic subunits of the SWI/SNF related BAF chromatin remodeling complex subunit...
      
6.
        
    
    Antonogiannaki E, Grigoropoulos I, Manali E, Thomas K, Kallieri M, Alexopoulou P, et al.
  
  
    J Clin Med
    . 2025 Jan;
          14(2.
    
    PMID: 39860353
  
  
          : Long-term lung sequelae in severe COVID-19 survivors, as well as their treatment, are poorly described in the current literature. : To investigate lung fibrotic sequelae in survivors of severe/critical...
      
7.
        
    
    Guiot J, Henket M, Gester F, Andre B, Ernst B, Frix A, et al.
  
  
    Respir Res
    . 2025 Jan;
          26(1):39.
    
    PMID: 39856708
  
  
          Background: Systemic sclerosis (SSc) is a rare connective tissue disease associated with rapidly evolving interstitial lung disease (ILD), driving its mortality. Specific imaging-based biomarkers associated with the evolution of lung...
      
8.
        
    
    Kotsiou O, Kirgou P, Tzouvelekis A, Kolilekas L, Manali E, Papiris S, et al.
  
  
    Sarcoidosis Vasc Diffuse Lung Dis
    . 2024 Dec;
          41(4):e2024055.
    
    PMID: 39655591
  
  
          Background And Aim: There is limited data on the prevalence of SARS-COV-2 in sarcoidosis patients and the underlying parameters linked to severity. We aimed to conduct a national multicenter study...
      
9.
        
    
    Tomos I, Papaioannou A, Daniil Z, Dimeas I, Kirgou P, Gogali A, et al.
  
  
    Adv Respir Med
    . 2024 Nov;
          92(6):466-471.
    
    PMID: 39584853
  
  
          : Depression and anxiety represent significant comorbidities in idiopathic pulmonary fibrosis (IPF) patients, affecting their quality of life. The COVID-19 pandemic has had an uneven impact on global mental health....
      
10.
        
    
    Dimakopoulou K, Tomos I, Manali E, Papiris S, Karakatsani A
  
  
    Expert Rev Respir Med
    . 2023 Nov;
          17(11):1069-1078.
    
    PMID: 37937867
  
  
          Background: Lately a potential detrimental effect of air pollution to idiopathic pulmonary fibrosis emerged. We aimed to assess the effects of short-term air pollution exposure to the clinical course of...